(MedPage Today) — Combination therapies for chronic lymphocytic leukemia (CLL) offer improved depth of response and potentially longer survival times compared with single-agent treatments. They target different pathways in CLL cells, leading to…
Source link : https://www.medpagetoday.com/spotlight/asco-cll/116084
Author :
Publish date : 2025-06-16 13:31:00
Copyright for syndicated content belongs to the linked Source.
